News
BIOL
0.1595
-0.75%
-0.0012
Weekly Report: what happened at BIOL last week (0513-0517)?
Weekly Report · 1d ago
BIOLASE -ON MAY 14, RECEIVED NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM NASDAQ
Reuters · 4d ago
Maxim Group downgrades Biolase (BIOL) to a Hold
TipRanks · 6d ago
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Alibaba Group Holding Limited fell sharply during Tuesday's session following mixed first-quarter financial results. The e-commerce giant reported revenue growth of 7% year-on-year but missed the analyst consensus estimate of $. Cheetah Net Supply Chain Service Inc. Shares jumped 136% to $ after a follow-on public offering.
Benzinga · 05/14 17:30
12 Health Care Stocks Moving In Tuesday's Intraday Session
Delcath Systems (NASDAQ:DCTH) stock rose to $ during Tuesday's regular session. The company's market cap stands at $ million. Harrow and ProKidney's Q1 earnings report came out today. Losers Scorpius Holdings (AMEX:SC Scorpius) and Augmedix ( NASDAQ:AUGX)
Benzinga · 05/14 16:31
Biolase Price Target Maintained With a $0.40/Share by Benchmark
Dow Jones · 05/14 15:53
Benchmark Reiterates Speculative Buy on Biolase, Maintains $0.4 Price Target
Benzinga · 05/14 15:43
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Alcon Inc. Rose sharply in today's pre-market trading following better-than-expected first-quarter earnings. Alcon posted adjusted earnings of 78 cents per share, beating market expectations of 63 cents. The company's quarterly sales came in at $ billion. GameStop Corp. And AMC Entertainment Holdings, Inc. Were among the stocks moving in pre- market trading.
Benzinga · 05/14 12:30
BIOL Stock Earnings: Biolase Misses EPS, Beats Revenue for Q1 2024
Biolase reported earnings per share of -20 cents for the first quarter of 2024. The company reported revenue of $ million. This was better than the analyst estimate for revenue of $ million. Biolase is a biotechnology company based in New York.
Investorplace · 05/14 00:53
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Press release · 05/13 21:10
Biolase Q1 2024 Adj EPS $(0.36) Misses $(0.17) Estimate, Sales $10.131M Beat $9.996M Estimate
Biolase reported quarterly sales of $ million. The company missed the analyst consensus estimate of $ million by percent. Biolase also reported quarterly losses of per share of $0.07 per share. The company beat the quarterly sales estimate by $1 million.
Benzinga · 05/13 20:07
BIOLASE Q1 REVENUE USD 10.131 MILLION
Reuters · 05/13 20:06
Weekly Report: what happened at BIOL last week (0506-0510)?
Weekly Report · 05/13 10:14
Notable earnings after Monday's close
Major earnings expected after the bell on Monday include: Petrobras, Lithium Americas and StoneCo Ltd. Other earnings slated for release after Monday's close include: Alcon and Inovio Pharmaceuticals. For Seeking Alpha's full earnings season calendar, click here.
Seeking Alpha · 05/12 21:35
Weekly Report: what happened at BIOL last week (0429-0503)?
Weekly Report · 05/06 10:18
Weekly Report: what happened at BIOL last week (0422-0426)?
Weekly Report · 04/29 10:22
Weekly Report: what happened at BIOL last week (0415-0419)?
Weekly Report · 04/22 10:17
Weekly Report: what happened at BIOL last week (0408-0412)?
Weekly Report · 04/15 10:11
12 Health Care Stocks Moving In Thursday's After-Market Session
Ontrak (NASDAQ:OTRK) shares increased by 18.7% to $0.45 during Thursday's after-market session. Ocuphire Pharma stock rose 7.82% and Lyell Immunopharma stock rose by 7.5%. Motus GI Hldgs stock declined by 32.6% during the after- market session.
Benzinga · 04/11 20:31
12 Health Care Stocks Moving In Wednesday's After-Market Session
Rallybio shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $81.2 million. Vera Therapeutics (NASDAQ:VERA) shares increased by 10.52% during the session.
Benzinga · 04/10 20:31
More
Webull provides a variety of real-time BIOL stock news. You can receive the latest news about Biolase Inc through multiple platforms. This information may help you make smarter investment decisions.
About BIOL
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.